ecabet has been researched along with thromboxane a2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwasaki, H; Kinoshita, M; Tamaki, H; Yasoshima, A | 1 |
| Kinoshita, M; Tamaki, H | 1 |
2 other study(ies) available for ecabet and thromboxane a2
| Article | Year |
|---|---|
Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats.
Topics: Abietanes; Animals; Anti-Ulcer Agents; Dinoprostone; Diterpenes; Epoprostenol; Gastric Mucosa; Intestinal Mucosa; Male; Microscopy, Electron, Scanning; Prostaglandins; Rats; Rats, Sprague-Dawley; Thromboxane A2 | 1993 |
Possible mechanism of increase in gastric mucosal PGE2 and PGI2 generation induced by ecabet sodium, a novel gastroprotective agent.
Topics: Abietanes; Animals; Anti-Ulcer Agents; Arachidonic Acid; Calcium; Dinoprostone; Diterpenes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoprostenol; Gastric Mucosa; Hydroxyprostaglandin Dehydrogenases; In Vitro Techniques; Male; Membrane Fluidity; Phospholipases A; Phospholipases A2; Quinacrine; Rats; Rats, Sprague-Dawley; Thromboxane A2 | 1997 |